Human Pai 1 Recombinant Single Point Mutation

Human PAI-1 Recombinant Single Point Mutation from Innovative Research has been recombinantly produced in E. coli and purified by affinity chromatography. This is a Frozen liquid buffered in 0.05M Sodium Phosphate; 0.1M NaCl; 1mM EDTA; pH 6.6 with a concentration of 2.5 mg/ml and a purity of >95% as determined by SDS-PAGE.

More Details:

• Species: Human
• Target: PAI-1
• Purification Method: Affinity purified
• Purity: >95% as determined by SDS-PAGE Analysis
• Source: E. coli
• Storage Conditions: -70 C

Additional Information:
Human PAI-1 with a single point mutation of Isoleucine 91 to Leucine. This provides stability for use in long-term binding experiments, and is suitable as a control for experiments involving non-LRP binding stable mutant PAI-1.

This product can be used as a control in applications like ELISA and Western Blot. It can be used in a wide range of in vitro applications, including blocking/inhibition, fibrinolysis, plasminogen activation, receptor binding, in hypertension studies, for protein-protein interactions, and more. At Innovative Research, we provide reliable, consistent products that deliver reliable, consistent results.